Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 415

recruiting
3 968
countries
28
conditions
2 103

10 282 trials match your criteria

Hepatocellular carcinoma+5

Not yet recruiting

Study on the Safety and Effectiveness of CEB-01 for Children with Resectable Tumors

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:7-Ethyl-10-Hydroxycamptothecin

Viral infection

Not yet recruiting

Study on the Effect of Povidone-Iodine, Hydrogen Peroxide, and Water for Injection on COVID-19, Influenza A, and RSV in Patients

Registered drug
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:HYDROGEN PEROXIDE

Diffuse large B-cell lymphoma+2

Not yet recruiting

Study of Loncastuximab Tesirine and Epcoritamab for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma, High-grade B-cell Lymphoma, or Follicular Lymphoma Grade 3B

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Epcoritamab

Psoriatic arthropathy

Not yet recruiting

Study on the Effectiveness of Ixekizumab and Methotrexate for Treating Dactylitis in Patients with Psoriatic Arthritis

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Ixekizumab

Study on the Effects of INT230-6, Vinblastine Sulfate, and Cisplatin in Patients with Early Triple-Negative Breast Cancer

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin

Study on the Safety and Effects of YTB323 and Drug Combination in Patients with Progressive Multiple Sclerosis

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Cyclophosphamide

Hypertrophic scar

Not yet recruiting

Study on Improving Burn Scars with Adipose-Derived Stem Cells and Autologous Stromal Vascular Fraction for Patients with Hypertrophic Scarring

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Adrc001

Prostate cancer

Not yet recruiting

Study on Relugolix and Radiation Therapy for Patients with Intermediate Risk Prostate Cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Relugolix
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab

Major depression

Not yet recruiting

Study on Thiopental Sodium Dose During Electroconvulsive Therapy for Patients with Major Depressive Disorder

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Thiopental Sodium

Obesity

Not yet recruiting

A study of orismilast alone or combined with semaglutide for weight management in people with obesity

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Orismilast

Colorectal cancer

Not yet recruiting

Study of 5-Fluorouracil, Panitumumab, and Sotorasib for Patients with Advanced KRAS G12C Mutated Colorectal Cancer Not Eligible for Standard Chemotherapy

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.